Blog
About

  • Record: found
  • Abstract: found
  • Article: found
Is Open Access

Nanoparticle Vaccines Against Infectious Diseases

Read this article at

Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Due to emergence of new variants of pathogenic micro-organisms the treatment and immunization of infectious diseases have become a great challenge in the past few years. In the context of vaccine development remarkable efforts have been made to develop new vaccines and also to improve the efficacy of existing vaccines against specific diseases. To date, some vaccines are developed from protein subunits or killed pathogens, whilst several vaccines are based on live-attenuated organisms, which carry the risk of regaining their pathogenicity under certain immunocompromised conditions. To avoid this, the development of risk-free effective vaccines in conjunction with adequate delivery systems are considered as an imperative need to obtain desired humoral and cell-mediated immunity against infectious diseases. In the last several years, the use of nanoparticle-based vaccines has received a great attention to improve vaccine efficacy, immunization strategies, and targeted delivery to achieve desired immune responses at the cellular level. To improve vaccine efficacy, these nanocarriers should protect the antigens from premature proteolytic degradation, facilitate antigen uptake and processing by antigen presenting cells, control release, and should be safe for human use. Nanocarriers composed of lipids, proteins, metals or polymers have already been used to attain some of these attributes. In this context, several physico-chemical properties of nanoparticles play an important role in the determination of vaccine efficacy. This review article focuses on the applications of nanocarrier-based vaccine formulations and the strategies used for the functionalization of nanoparticles to accomplish efficient delivery of vaccines in order to induce desired host immunity against infectious diseases.

      Related collections

      Most cited references 227

      • Record: found
      • Abstract: found
      • Article: not found

      Understanding biophysicochemical interactions at the nano-bio interface.

      Rapid growth in nanotechnology is increasing the likelihood of engineered nanomaterials coming into contact with humans and the environment. Nanoparticles interacting with proteins, membranes, cells, DNA and organelles establish a series of nanoparticle/biological interfaces that depend on colloidal forces as well as dynamic biophysicochemical interactions. These interactions lead to the formation of protein coronas, particle wrapping, intracellular uptake and biocatalytic processes that could have biocompatible or bioadverse outcomes. For their part, the biomolecules may induce phase transformations, free energy releases, restructuring and dissolution at the nanomaterial surface. Probing these various interfaces allows the development of predictive relationships between structure and activity that are determined by nanomaterial properties such as size, shape, surface chemistry, roughness and surface coatings. This knowledge is important from the perspective of safe use of nanomaterials.
        Bookmark
        • Record: found
        • Abstract: found
        • Article: not found

        Neutrophil recruitment and function in health and inflammation.

        Neutrophils have traditionally been thought of as simple foot soldiers of the innate immune system with a restricted set of pro-inflammatory functions. More recently, it has become apparent that neutrophils are, in fact, complex cells capable of a vast array of specialized functions. Although neutrophils are undoubtedly major effectors of acute inflammation, several lines of evidence indicate that they also contribute to chronic inflammatory conditions and adaptive immune responses. Here, we discuss the key features of the life of a neutrophil, from its release from bone marrow to its death. We discuss the possible existence of different neutrophil subsets and their putative anti-inflammatory roles. We focus on how neutrophils are recruited to infected or injured tissues and describe differences in neutrophil recruitment between different tissues. Finally, we explain the mechanisms that are used by neutrophils to promote protective or pathological immune responses at different sites.
          Bookmark
          • Record: found
          • Abstract: found
          • Article: not found

          Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

          Toll-like receptors (TLRs) are germline-encoded pattern recognition receptors (PRRs) that play a central role in host cell recognition and responses to microbial pathogens. TLR-mediated recognition of components derived from a wide range of pathogens and their role in the subsequent initiation of innate immune responses is widely accepted; however, the recent discovery of non-TLR PRRs, such as C-type lectin receptors, NOD-like receptors, and RIG-I-like receptors, suggests that many aspects of innate immunity are more sophisticated and complex. In this review, we will focus on the role played by TLRs in mounting protective immune responses against infection and their crosstalk with other PRRs with respect to pathogen recognition. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark

            Author and article information

            Affiliations
            1School of Biotechnology, KIIT University , Bhubaneswar, India
            2Institute of Cytology of the Russian Academy of Sciences (RAS) , St. Petersburg, Russia
            3Klinikum Rechts der Isar, Technical University of Munich , Munich, Germany
            4First Pavlov State Medical University of St.Petersburg , St. Petersburg, Russia
            5Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore , Indore, India
            Author notes

            Edited by: Nahid Ali, Indian Institute of Chemical Biology, India

            Reviewed by: Randy A. Albrecht, Icahn School of Medicine at Mount Sinai, United States; Michael Schotsaert, Icahn School of Medicine at Mount Sinai, United States; Katie Louise Flanagan, RMIT University, Australia

            *Correspondence: Avinash Sonawane asonawane@ 123456iiti.ac.in

            This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology

            Contributors
            Journal
            Front Immunol
            Front Immunol
            Front. Immunol.
            Frontiers in Immunology
            Frontiers Media S.A.
            1664-3224
            04 October 2018
            2018
            : 9
            6180194
            10.3389/fimmu.2018.02224
            Copyright © 2018 Pati, Shevtsov and Sonawane.

            This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

            Counts
            Figures: 2, Tables: 1, Equations: 0, References: 228, Pages: 16, Words: 14090
            Funding
            Funded by: Department of Scientific and Industrial Research, Ministry of Science and Technology 10.13039/501100001408
            Award ID: SR/NM/NS-1159/2016
            Funded by: Alexander von Humboldt-Stiftung 10.13039/100005156
            Categories
            Immunology
            Review

            Comments

            Comment on this article